Written Communication Relating to an Issuer or Third Party (sc To-c)
November 21 2017 - 2:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported) November 21, 2017
SUNLINK HEALTH SYSTEMS, INC.
(Exact Name Of Registrant As Specified In Charter)
|
|
|
|
|
Ohio
|
|
1-12607
|
|
31-0621189
|
(State or other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
900 Circle 75 Parkway, Suite 1120, Atlanta, Georgia
|
|
30339
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code (770) 933-7000
(Former Name Or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (
see
General Instruction A-2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☒
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or
Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On November 21, 2017, the Registrant issued a press release announcing
that it intends to commence, within the next week, a tender offer to purchase up to 1,562,500 of its common shares at a price of $1.60 per share. A copy of the press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 9.01
|
Financial Statements and Exhibits.
|
(d)
Exhibits
. The following exhibit is filed
herewith:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be
signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
SUNLINK HEALTH SYSTEMS, INC.
|
|
|
By:
|
|
/s/ Mark J. Stockslager
|
Name:
|
|
Mark J. Stockslager
|
Title:
|
|
Chief Financial Officer
|
Dated: November 21, 2017
Sunlink Health Systems (AMEX:SSY)
Historical Stock Chart
From Apr 2024 to May 2024
Sunlink Health Systems (AMEX:SSY)
Historical Stock Chart
From May 2023 to May 2024